CHARLES RIVER LABORATORIES INTERNATIONAL INC

For the period ended Dec 30, 2023. Filed Feb 14, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 14, 2024

CRL$353.34+4.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Financial Statements and Supplementary Data

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm (PCAOB ID 238)	55
Consolidated Statements of Income for fiscal years 2023, 2022 and 2021	58
Consolidated Statements of Comprehensive Income for fiscal years 2023, 2022 and 2021	59
Consolidated Balance Sheets as of December 30, 2023 and December 31, 2022	60
Consolidated Statements of Cash Flows for fiscal years 2023, 2022 and 2021	61
Consolidated Statements of Changes in Equity for fiscal years 2023, 2022 and 2021	62
Notes to Consolidated Financial Statements	63
Note 1. Description of Business and Summary of Significant Accounting	63
Note 2. Acquisitions and Divestitures	71
Note 3. Revenue from Contracts with Customers	77
Note 4. Segment and Geographic Information	79
Note 5. Supplemental Cash Flow Information	80
Note 6. Inventory	80
Note 7. Property, Plant and Equipment, Net	80
Note 8. Venture Capital Investments and Marketable Securities	81
Note 9. Fair Value	81
Note 10. Goodwill and Intangible Assets	83
Note 11. Debt and Other Financing Arrangements	84
Note 12. Equity and Noncontrolling Interest	86
Note 13. Income Taxes	89
Note 14. Employee Benefit Plans	91
Note 15. Stock-based Compensation	95
Note 16. Restructuring and Asset Impairments	97
Note 17. Leases	99
Note 18. Commitments and Contingencies	101

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.